2021 American Transplant Congress
Paired Exchanges in LDLT- A Good Option for Patients with Incompatible Donors
University of Pittsburgh, Pittsburgh, PA
*Purpose: In the US, paired exchanges are common for LD kidney transplant but not for LDLT. We present our series of paired exchanges for LDLT,…2021 American Transplant Congress
The Risk of Post-donation Kidney Function Impairment for Prospective Living Kidney Donors with Persistent Isolated Microscopic Hematuria
*Purpose: According to current guidelines, a kidney biopsy is indicated in prospective living kidney donors who present with persistent isolated microscopic hematuria (PIMH) during evaluation,…2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…2021 American Transplant Congress
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
University of Cincinnati, Cincinnati, OH
*Purpose: Medically complex donors are increasingly being assessed for donation. Due to concern for donor safety, there is a wide variation amongst transplant providers in…2021 American Transplant Congress
Impact of COVID-19 Crisis on Disparities in Living Kidney Donation in the US
*Purpose: The COVID-19 pandemic resulted in a dramatic decrease in living kidney donation (LKD) in the U.S. This study investigated the effect of the COVID…2021 American Transplant Congress
Impact of Advanced Renal Dysfunction on Post-Transplant Outcomes After Living Donor Liver Transplantation in the United States
*Purpose: Survival after living donor liver transplantation (LDLT) in the U.S. is excellent. However, the significance of pre-transplant kidney disease on outcomes after LDLT is…2021 American Transplant Congress
Living Donor Kidney Transplantation Racial Disparities Persist Independent of Social Vulnerability
*Purpose: Living donor kidney transplantation (LDKT) confers a significant survival benefit over deceased donor transplantation. Racial disparities in access to LDKT are well recognized, yet…2021 American Transplant Congress
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
*Purpose: Development of de novo donor-specific anti-HLA antibodies (dnDSA) after kidney transplantation remains strongly associated with antibody-mediated rejection (AMR), which leads to poor graft outcome.…2021 American Transplant Congress
Development and Validation of a Nomogram for Remnant Kidney Function After Living-donor Donation
The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
*Purpose: This study was to develop and validate a nomogram to predict remnant kidney function after living-donor kidney donation.*Methods: We conducted a retrospective cohort study…2021 American Transplant Congress
Dual Liver and Kidney Donors, What Makes Them Decide to Do It?
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: There is incongruity between the transplant waiting list and the number of deceased donors available, therefore there is an enduring challenge to increase the…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 27
- Next Page »